- Calliditas Strengthens its US Commercial Organization
- Calliditas Moves its Annual General Meeting 2020 to June 25
- Calliditas Therapeutics - Year-End Report 2019
- Positive Opinion Received From EMA Paediatric Committee on the Paediatric Investigation Plan for Nefecon for the Treatment of IgAN
- Calliditas Submits Draft Registration Statement for the Listing of ADSs in the U.S.
As of last trade,
Calliditas Therapeutics AB (LC8:BER) traded at 7.63, 82.10% above the 52 week low of 4.19 set on Apr 10, 2019.
4.19Apr 10 201911.52Feb 07 2020
Markit short selling activity
|Market cap||3.18bn SEK|
|EPS (TTM)||-0.7567 |
Data delayed at least 15 minutes, as of Apr 02 2020 16:45 BST.